Document Detail


Effect of calcium and vitamin D supplementation on toxaemia of pregnancy.
MedLine Citation:
PMID:  3623260     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
To study the effect of calcium and vitamin D supplementation on the incidence of toxaemia of pregnancy, 200 randomly selected pregnant women (supplemented group), were put on calcium (375 mg/day) and vitamin D (1,200 IU/day) supplements at 20-24 weeks of pregnancy onwards. Another 200 pregnant women constituted the non-supplemented group. At 32 and 36 weeks of pregnancy the systolic and diastolic blood pressure of non-toxemic women was significantly lower in the supplemented group than in the non-supplemented group. However, the incidence of toxaemia in the supplemented group (6%) was not significantly different from that in the non-supplemented group (9%).
Authors:
R K Marya; S Rathee; M Manrow
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  Gynecologic and obstetric investigation     Volume:  24     ISSN:  0378-7346     ISO Abbreviation:  Gynecol. Obstet. Invest.     Publication Date:  1987  
Date Detail:
Created Date:  1987-10-15     Completed Date:  1987-10-15     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  7900587     Medline TA:  Gynecol Obstet Invest     Country:  SWITZERLAND    
Other Details:
Languages:  eng     Pagination:  38-42     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Blood Pressure / drug effects
Calcium, Dietary / pharmacology,  therapeutic use*
Female
Humans
Pre-Eclampsia / prevention & control*
Pregnancy
Vitamin D / pharmacology,  therapeutic use*
Chemical
Reg. No./Substance:
0/Calcium, Dietary; 1406-16-2/Vitamin D

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Prospective study of velocity waveforms in the fetal descending thoracic and abdominal aorta in fetu...
Next Document:  Use of bromocriptine in the treatment of normoprolactinemic infertility.